New Therapy Could Eliminate HIV in Newborns Within 3 Days

Every year, 120,000 babies worldwide are born with HIV, facing a lifetime of expensive medication. Now, researchers have discovered a treatment that could clear the virus completely with just one early intervention.

Scientists at Oregon Health & Science University tested a combination of three therapies on newborn primates infected with HIV. When given within three days of birth, the treatment permanently eliminated the virus from their systems.

The research team combined treatments that had each failed individually: neutralizing antibodies, standard antiretroviral therapy, and an experimental drug called leronlimab. Lead researcher Jonah Sacha admits he was skeptical the combination would work any better than the individual treatments alone.

"There was no reason to think this would completely clear the virus," Sacha said. "It's one of those things where you test it and, holy cow, it works and you've discovered something new."

His colleague Nancy Haigwood, who suggested combining the therapies, was equally surprised. "We were astounded and overjoyed, actually," she said. "It's a remarkable result."

The treatment works like a three-step defense system. Antiretroviral therapy stops HIV from copying itself. Neutralizing antibodies reduce the amount of virus circulating in the blood. Leronlimab then blocks any remaining virus from entering immune cells through a protein called CCR5.

"By blocking access, it's like you've kept fuel away from the fire," Sacha explained. The virus relies heavily on CCR5 to infect cells, so cutting off that pathway appears to starve it completely.

The timing seems critical. Haigwood believes the combination is especially powerful during the first week of infection, when complex interactions between the virus and antibodies are just beginning.

Why This Inspires

This discovery represents more than a laboratory achievement. It offers genuine hope for eliminating HIV in newborns before the virus can establish itself permanently. Two of the three treatments are already approved or in clinical trials, meaning the path to human testing could be remarkably fast.

The research team is eager to explore whether the treatment window extends beyond 72 hours. "Could it work a week after infection? Two weeks?" Sacha asks. "How far can you go after infection and still purge the virus?"

The next step involves clinical trials in newly exposed adults before testing in newborns. Given the anatomical similarities between primates and humans, researchers are optimistic the results will translate successfully.

For the 600,000 people who still die from HIV-related illnesses each year, and the millions more living with the virus, this breakthrough represents a turning point. The researchers believe their discovery could eventually help eliminate HIV infection in newborns worldwide, transforming what was once a death sentence into a one-time, preventable condition.